Subregion-specific 18F-FDG PET-CT radiomics for the pre-treatment prediction of EGFR mutation status in solid lung adenocarcinoma
American Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.62347/ddrr4923 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Yun Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Zhejiang Cancer Hospital Hangzhou 310022, Zhejiang, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Zhejiang Cancer Hospital Hangzhou 310022, Zhejiang, China.
- Department of Physics, Shanghai Key Laboratory of Magnetic Resonance, East China Normal University Shanghai 200062, China.
- Department of Radiology, Zhejiang Cancer Hospital Hangzhou 310022, Zhejiang, China.
Zitieren
APA
Wang, Y., Yang, G., Gao, X., Li, L., Zhu, H., & Yi, H. (2024). Subregion-specific 18F-FDG PET-CT radiomics for the pre-treatment prediction of EGFR mutation status in solid lung adenocarcinoma. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/ddrr4923
Vancouver
Wang Y, Yang G, Gao X, Li L, Zhu H, Yi H. Subregion-specific 18F-FDG PET-CT radiomics for the pre-treatment prediction of EGFR mutation status in solid lung adenocarcinoma. American Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.62347/ddrr4923
BibTeX
@article{Wang2024,
author = {Wang, Yun and Yang, Guang and Gao, Xinyi and Li, Linfa and Zhu, Hongzhou and Yi, Heqing},
title = {Subregion-specific 18F-FDG PET-CT radiomics for the pre-treatment prediction of EGFR mutation status in solid lung adenocarcinoma},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.62347/ddrr4923}
}
EUVIMED